Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Regeneron Pharmaceuticals (REGN34.SA) Q2 2022 Earnings
REGN34.SA
4
May
Confirmed
Q3 2021
Q4 2021
Q1 2022
Q2 2022
43.92
74.39
104.86
135.33
Details
Expected EPS
47.909112
Actual EPS
43.924884
Surprise EPS
-3.98
Surprise Percent
+8.32%
Description
Regeneron Pharmaceuticals (REGN34.SA) has reported earnings of 43.924884 per share for Q2 2022.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login